Biblio
S
Belada D, Kopeckova K, Burgues JMiguel Ber, Stevens D, André M, Persona EPerez, Pichler P, Staber PB, Trneny M, Duell J, et al. Safety and efficacy of tafasitamab ± lenalidomide added to first-line R‑CHOP for DLBCL: Phase 1b First-MIND study. Blood. 2023.